OnKure Therapeutics OKUR
NASDAQ OKUR
$2.54 -0.04 (-1.55%)
As of: Oct 23, 2026 · 2:42 PM EDT

OnKure Therapeutics (OKUR) Revenue (2024 - 2026)

Updated

Analysis

OnKure Therapeutics (OKUR) Revenue (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,124.12 Bn 1,092.71 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 634.38 Bn 554.24 Bn 17.30 Bn 25.40 Bn
3 AbbVie 505.39 Bn 478.50 Bn 12.70 Bn 16.99 Bn
4 Merck 357.36 Bn 311.74 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 290.21 Bn 254.20 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 265.21 Bn 238.89 Bn 12.86 Bn 15.38 Bn
7 Amgen 237.81 Bn 193.21 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn 7.80 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 15.03 Bn
10 OnKure Therapeutics 126.67 Mn -371.26 Mn - 1.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.55 Mn
Mar 31, 2026 458,000.00
Dec 31, 2025 622,000.00
Sep 30, 2025 802,000.00
Jun 30, 2025 934,000.00
Mar 31, 2025 1.08 Mn
Dec 31, 2024 1.20 Mn
Sep 30, 2024 -44,000.00
Jun 30, 2024 204,000.00
API Access

OnKure Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=OKUR&period=max&api_key=YOUR_API_KEY